Lead Longevity Editor’s Clinical Summary: Marine-derived Omega-3 fatty acids—specifically Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA)—are among the most rigorously researched, clinically validated nutraceuticals in veterinary medicine. Yet over 80% of dog owners underdose or administer oxidized, ineffective oils. While flaxseed oil provides Alpha-Linolenic Acid (ALA), dogs lack the delta-6-desaturase enzyme required to convert ALA into active EPA/DHA efficiently (<1% conversion). Achieving clinical anti-inflammatory efficacy for osteoarthritis, chronic kidney disease, and cognitive health requires weight-calibrated marine dosing.

Omega-3 fatty acids exert their therapeutic action through competitive inhibition. By replacing arachidonic acid (an Omega-6 fat) in cell membrane phospholipid bilayers, EPA downregulates the production of pro-inflammatory 2-series prostaglandins and 4-series leukotrienes, generating mild, anti-inflammatory 3-series and 5-series mediators instead.

What Is the Exact Veterinary Dosage of EPA and DHA for Dogs?

Direct Answer: Clinical dosages are based on combined milligrams of EPA + DHA per kilogram of body weight, NOT total ‘fish oil’ volume. For canine osteoarthritis, the evidence-backed target is 100 mg to 125 mg of combined EPA+DHA per kg of body weight daily. For chronic kidney disease and cardiovascular health, the target is 75 mg to 100 mg per kg daily.

Most commercial pet ‘fish oil pumps’ provide only 200 mg to 300 mg of active EPA/DHA per squirt while claiming a ‘1,000 mg fish oil’ label. For a 30 kg (66 lb) golden retriever battling severe hip dysplasia, the required therapeutic dose is approximately 3,000 mg to 3,750 mg of active EPA+DHA—requiring 10 to 12 pumps of low-potency commercial oil.

Clinical Indication Target EPA + DHA Dose Primary Functional Ratio Biological Mechanism of Action
Osteoarthritis & Joint Pain 100 – 125 mg / kg / day EPA-dominant (~1.5:1 EPA:DHA) Inhibits aggrecanase and collagenase degradation in synovial cartilage.
Chronic Kidney Disease (CKD) 75 – 100 mg / kg / day EPA-dominant (~2:1 EPA:DHA) Lowers intraglomerular capillary pressure; prevents proteinuria progression.
Cognitive Dysfunction (Dementia) 50 – 75 mg / kg / day DHA-dominant (~1:2 EPA:DHA) Maintains neuronal membrane fluidity; reduces amyloid-beta plaque aggregation.
Atopic Dermatitis (Itchy Skin) 125 – 150 mg / kg / day Balanced (1:1 EPA:DHA) Restores epidermal lipid moisture barrier; decreases pruritic leukotriene B4.

Why Should You Choose Triglyceride Form Over Ethyl Ester Fish Oil?

Direct Answer: Re-esterified Triglyceride (rTG) fish oils boast up to 70% higher bioavailability and absorption kinetics in canines compared to semi-synthetic Ethyl Ester (EE) formulations. Furthermore, polyunsaturated oils oxidize rapidly when exposed to air and light; liquid pump bottles left at room temperature develop toxic lipid peroxides that cause gastrointestinal irritation and cellular oxidative stress.

Always purchase Omega-3 supplements in opaque glass bottles or individual blister-pack softgels, and store liquid oils in the refrigerator after opening. Because high-dose Omega-3 therapy competes with fat-soluble antioxidants, dogs receiving therapeutic fish oil should also receive supplemental natural Vitamin E (alpha-tocopherol, ~1–2 IU per lb body weight) to prevent systemic lipid peroxidation.

Chief Longevity Editor’s Clinical Advisory: “Always calculate your dog’s dose using the EPA and DHA line items on the guaranteed analysis panel, never the front label’s generic ‘Salmon Oil 1,000mg’. If a product doesn’t explicitly disclose the exact milligrams of EPA and DHA per serving, it is filler oil that will deliver zero clinical benefit for your dog’s joints.”
Related Canine Cellular Aging Biology Teardown:

To understand the metabolic scaling laws and cellular mechanisms that dictate canine lifespan across breeds, read our scientific report on Why Small Dogs Live Longer: Canine Aging Biology Guide.